NASDAQ:ALIM
Alimera Sciences, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Drug Manufacturers - Specialty & Genericwebsite
alimerasciences.comipo date
Nov 04, 2019
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindnes...Show More
Earnings
Earnings Release in 4 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus